GDTC (CytoMed) Earnings per share growth rate in current year
Growth for CytoMed Therapeutics (GDTC) is driven by progress in developing allogeneic tumor therapies and interest from big pharma. The annual EPS growth rate reflects current dynamics, with the figure fixed at 0.00. The strategy is based on the development of affordable CAR-T and CAR-NK drugs. Venture potential relies on early patents and the Singaporean platform, despite the risks associated with clinical stages.
Analytical breakdowns and data insights for company w2.cytomed.sg (GDTC)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt burden and liquidity indicators:
- net income and valuation ratios data:
GDTC - Net Income|Expected Net Income CytoMed Therapeutics|GDTC - Price to Earnings Ratio|Market Cap to Future Earnings Ratio CytoMed Therapeutics Ltd|GDTC - PEG Multiple|Business Value to Operating Income Before Depreciation CytoMed Therapeutics|GDTC - Operating profit EBITDA|Net earnings per one share for the last twelve months CytoMed Therapeutics|GDTC - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months w2.cytomed.sg|GDTC - Earnings growth in current year|Earnings growth forecast for next year CytoMed Therapeutics
- company sales and revenue statistics:
Basic company analysis:GDTC, CytoMed Therapeutics
CytoMed Therapeutics (GDTC) focuses on expanding clinical trials in the field of cancer immunotherapy. This 12-month relative EPS growth indicator captures the percentage change in net profit per share compared to the previous year. The metric demonstrates the speed at which the market absorbs new business data, excluding emotional noise. The stability of management's scientific foundation directly influences the trajectory of this chart. Positive dynamics confirm capital resilience and the confidence of specialized funds.
Direct competitors
Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|PSNL - Earnings per share growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth in current year|Net earnings per share growth this year AURA|Earnings per share growth rate in current year candeltx.com CADL|Earnings growth in current year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Earnings per share increase in current year|Earnings growth in current year ACTU (Actuate Therapeutics Inc)|Earnings per share increase in current year CTOR|tuhurabio.com - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Earnings per share growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year tscan.com|CSBR: Earnings per share increase in current year|Earnings per share growth in current year XBiotech USA (XBIT)|CVM: Earnings per share trend in current year|Earnings per share growth in current year ostherapies.com OSTX|Net earnings per one share growth for the current year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth in current year|ANL: Earnings per share growth in current year|VERU: Earnings growth in current year|Earnings per share trend in current year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth in current year|Earnings per share growth rate in current year renovarobio.com RENB|Earnings per share growth in current year muraloncology.com (MURA)|Net earnings per one share growth for the current year KAPA|Earnings growth in current year OKUR (onkuretherapeutics.com)|CRIS: Earnings per share growth this year|APLM - Earnings per share growth in current year|THAR - Earnings growth in current year|ADVB: Earnings growth in current year|Earnings per share growth this year GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year SBFM|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma
